These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10454446)

  • 21. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC; El Aouar LM; Mill JG
    Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
    Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
    Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
    Cooper ME; Allen TJ; O'Brien RC; Papazoglou D; Clarke BE; Jerums G; Doyle AE
    Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload.
    Tokioka-Akagi T; Fujimori A; Shibasaki M; Inagaki O; Yanagisawa I
    Jpn J Pharmacol; 2001 May; 86(1):79-85. PubMed ID: 11430476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
    Makino N; Sugano M; Otsuka S; Hata T
    Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats.
    Blezer EL; Nicolay K; Koomans HA; Joles JA
    Am J Hypertens; 2001 Jan; 14(1):54-61. PubMed ID: 11206680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of cardiac hypertrophy after therapy in animal hypertension.
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S56-61. PubMed ID: 2409372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.
    De Ciuceis C; Flati V; Rossini C; Rufo A; Porteri E; Di Gregorio J; Petroboni B; La Boria E; Donini C; Pasini E; Agabiti Rosei E; Rizzoni D
    Blood Press; 2014 Dec; 23(6):330-8. PubMed ID: 24786779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [High blood pressure and cardiac hypertrophy].
    Ishikawa Y
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():342-6. PubMed ID: 15171396
    [No Abstract]   [Full Text] [Related]  

  • 30. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
    Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists and/or the angiotensin II type 1 receptor blocker under comparable blood pressure reduction.
    Asai T; Kushiro T; Fujita H; Kanmatsuse K
    Hypertens Res; 2005 Jan; 28(1):79-87. PubMed ID: 15969258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.
    Devereux RB; Palmieri V; Sharpe N; De Quattro V; Bella JN; de Simone G; Walker JF; Hahn RT; Dahlöf B
    Circulation; 2001 Sep; 104(11):1248-54. PubMed ID: 11551875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
    Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
    Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.
    Nunez E; Hosoya K; Susic D; Frohlich ED
    Hypertension; 1997 Jan; 29(1 Pt 2):519-24. PubMed ID: 9039153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis.
    Sabino B; Lessa MA; Nascimento AR; Rodrigues CA; Henriques Md; Garzoni LR; Levy BI; Tibiriçá E
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):402-9. PubMed ID: 18427284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
    Karpov IuA
    Kardiologiia; 2005; 45(12):87-92. PubMed ID: 16353053
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
    Otsuka S; Sugano M; Makino N; Sawada S; Hata T; Niho Y
    Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats.
    Ruzicka M; Yuan B; Leenen FH
    Circulation; 1994 Jul; 90(1):484-91. PubMed ID: 8026035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent lowering of arterial pressure after continuous and intermittent therapy.
    Woolard J; Hale TM; Bushfield TL; Adams MA
    J Hypertens; 2003 Apr; 21(4):813-20. PubMed ID: 12658029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of adrenergic receptors during regression of cardiac hypertrophy.
    Matsui H; Makino N; Yano K; Nakanishi H; Hata T; Yanaga T
    J Hypertens; 1994 Dec; 12(12):1353-7. PubMed ID: 7706693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.